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Results: We were able to demonstrate the feasibility of our new 
acquisition technique for peak-inhale only, peak-exhale only, and mid-
ventilation only short (200°) and full scanning protocols. In the figure, 
a significant reduction in motion-related artefacts at the tumour 
surface is demonstrated. Reconstruction artefacts stemming from the 
presence of the EM-array were greatly reduced. Inherently, the 
method leads to a smooth distribution of projection angles over the 
entire gantry rotation. A typical CTDI imaging dose for a peak-exhale 
(360°, 375 fr., 5 min)/peak-inhale (200°, 106 fr., 2:47 min) protocol is 
~8/~2 mGy. 
 
  
Conclusions: We have implemented a new dose-saving 4D CBCT 
scanning protocol which reduces motion-artefacts by selecting the 
breathing phase(s) desired for reconstruction prior to image 
acquisition. We are currently implementing the acquisition of multiple 
phases in one gantry rotation. 
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Purpose/Objective: To develop and evaluate a tumour tracking 
method for the dynamic localization of extra-cranial targets during 
radiotherapy treatments, providing the continuous monitoring and 
compensation of intra-fraction organ motion due to breathing. The 
proposed approach is based on external surface surrogates estimated 
from non-invasive optical devices, and on patient-specific adaptive 
motion models derived from time-resolved planning and in-room X-ray 
imaging systems. 
Materials and Methods: A patient-specific motion model, 
parameterized as a function of the respiratory tumour baseline, 
amplitude and phase, is estimated from 4D CT planning images, by 
applying B-spline deformable registration between each 4D CT phase 
and the mid-position CT volume.The tumour baseline is adapted at 
each treatment fraction according to daily information on target 
localization derived from volumetric CBCT images. The breathing 
amplitude and phase parameters are retrieved from the external 
surface motion, acquired with 3D surface imaging systems. 
Deformable mesh registration is applied to derive the spatial 
correspondence between markerless optical surfaces. The obtained 3D 
trajectories of all thoraco-abdominal surface points are summarized 
into a single respiratory surrogate signal through k-means clustering 
techniques. The instantaneous values of the respiratory phase are 
extracted from the surface surrogate using the Hilbert transform. The 
amplitude scaling factor is obtained by comparing surface motion 
amplitudes during treatment planning and delivery. The adapted 
breathing parameters are integrated in the 4D CT motion model to 
estimate intra-fraction 3D tumor motion. 
Results: The developed tumour tracking method was tested on a 
clinical database of seven lung cancer patients, including the 
synchronized information on the external surface and internal tumour 
breathing motion during CBCT scans. About 30 seconds of 
synchronized acquisition of CBCT projections and optical surfaces, 
captured with the VisionRT system, were analyzed for each patient. 
The tumour trajectories estimated from surface displacement 
combined with the a priori 4D CT motion model were compared to the 
real target trajectories identified on CBCT images. The resulting 
absolute differences between real and estimated tumour motion 
ranged between 0.7 and 2.4 mm, with median values of 1.5 mm both 
along the horizontal and vertical image dimensions (Table 1). The 
measured phase shifts did not exceed the 7% of the breathing cycle 
length. 
 
  
Conclusions: The developed tumor tracking method proved to be 
effective in estimating tumour motion from the external surface 
displacement even in presence of breathing irregularities, as depicted 
in Figure 1. The innovative methodological aspects, related to the use 
of patient-specific adaptive motion models and to the redundancy of 
markerless surface data, are put forward to improve the accuracy and 
robustness of targeting techniques for intra-fraction organ motion 
compensation. 
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Purpose/Objective: In radiotherapy, fiducial markers are often 
implanted in the liver and used as x-ray visible surrogates for the 
tumour position. The basic assumption is that the tumour maintains a 
constant position relative to the marker throughout the treatment 
course. The aim of this study was to investigate the validity of this 
assumption by quantifying the geometric accuracy by which one 
implanted marker can predict the position of another marker in the 
liver.  
Materials and Methods: 26 patients with 2-3 implanted gold markers 
received stereotactic body radiation therapy to liver lesions in 3-6 
treatment fractions. At each fraction a cone-beam CT (CBCT) scan 
was acquired and used for marker based patient setup. After the 
treatments each marker was segmented in the projections of the 
CBCT scans, and the resulting 2D marker trajectories were used to 
estimate the 3D trajectory of each marker in patientspace by a 
probability based method. In total 198 3D marker trajectories with a 
mean duration of 51 seconds were recorded at 11 Hz over 90 
treatment fractions. The markers in the data set constituted 54 
marker pairs in total. For each marker pair, the error in estimating 
the 3D position of one marker from the 3D position of the other 
marker was calculated for each time point as the difference in the 3D 
shifts the two markers away from their respective mean positions. The 
root-mean-square (RMS) of this error was calculated for each marker 
pair as a measure for the intrafraction prediction error, during all 
fractions. Similarly, the interfraction RMS estimation error was 
calculated for each marker pair from the changes in the relative 3D 
mean marker positions from fraction to fraction.  
Results: The 3D position of an implanted marker was estimated from 
the position of another marker with a mean RMS error of 0.35 (LR), 
0.59 mm (CC), 0.47 mm (AP), and 0.86 +-0.57 mm (3D) intra-
fractionally, and of 0.52 mm (LR), 0.60 mm (CC), 0.59 mm (AP), and 
